PT - JOURNAL ARTICLE AU - Geiger, McKena AU - Hurewitz, Sophie R. AU - Pawlowski, Katherine AU - Baumer, Nicole T. AU - Wilkinson, Carol L. TI - Alterations in aperiodic and periodic EEG activity in young children with Down syndrome AID - 10.1101/2024.05.01.24306729 DP - 2024 Jan 01 TA - medRxiv PG - 2024.05.01.24306729 4099 - http://medrxiv.org/content/early/2024/05/04/2024.05.01.24306729.short 4100 - http://medrxiv.org/content/early/2024/05/04/2024.05.01.24306729.full AB - Down syndrome is the most common cause of intellectual disability, yet little is known about the neurobiological pathways leading to cognitive impairments. Electroencephalographic (EEG) measures are commonly used to study neurodevelopmental disorders, but few studies have focused on young children with DS. Here we assess resting state EEG data collected from toddlers/preschoolers with DS (n=29, age 13-48 months old) and compare their aperiodic and periodic EEG features with both age-matched (n=29) and cognitive-matched (n=58) comparison groups. DS participants exhibited significantly reduced aperiodic slope, increased periodic theta power, and decreased alpha peak amplitude. A majority of DS participants displayed a prominent peak in the theta range, whereas a theta peak was not present in age-matched participants. Overall, similar findings were also observed when comparing DS and cognitive-matched groups, suggesting that EEG differences are not explained by delayed cognitive ability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the National Institutes of Health (R01-DC010290, K23DC07983 and T32MH112510 to CLW) and The Tapley Family Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Boston Children's Hospital gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes